Yahoo Malaysia Web Search

Search results

  1. Illumina is a company that provides next-generation sequencing and microarray technology to advance genomic research and applications. Learn about their products, services, innovations, and impact in various fields of science and health.

    • View Webinars

      At Illumina, our goal is to apply innovative technologies to...

    • Sequencing

      Illumina sequencing enables a wide variety of applications,...

    • Stock Information

      At Illumina, Inc., we promise to treat your data with...

  2. Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

  3. Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core...

  4. From cancer research to prenatal screening to food safety, the applications are as universal as life itself. Learn More. Our goal is to transform human health by applying innovative genomics technologies to the analysis of genetic variation and function.

  5. Get the latest Illumina Inc (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  6. 3. $200 USD genome on NovaSeq X Series is delivered at list price on 25B flow cell. Data on file. Illumina, Inc. 2023. 4. Main campus locations currently include San Diego, Foster City, Hayward, UK Illumina Centre, Netherlands, and Singapore Woodlands. M-GL-01040 v3.0 $100 million USD2 $200 USD3 Applications • Oncology • Genetic disease

  7. Jan 10, 2022 · January 10, 2022. Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally.